Mannkind (MNKD) Receivables - Other (2010 - 2023)

Mannkind's (MNKD) quarterly Receivables - Other came in at $400000.0 in Q3 2023, down 33.33% year-on-year from $600000.0 in Q3 2022, and up 100.0% on a QoQ basis from $200000.0 in Q2 2023.

Mannkind (MNKD) Receivables - Other (2010 - 2023) Analysis & Trends

Mannkind (MNKD) has 8 years of Receivables - Other data on file, last reported at $400000.0 in Q3 2023.

  • On a quarterly basis, Receivables - Other fell 33.33% year-over-year to $400000.0 in Q3 2023; TTM through Sep 2023 was $400000.0, a 33.33% decrease from a year earlier, with the FY2021 full-year figure at $300000.0, changed N/A from the prior year.
  • Receivables - Other for Q3 2023 stood at $400000.0, up from $200000.0 in the prior quarter.
  • Over the last five years, Receivables - Other for MNKD reached as high as $700000.0 in Q1 2023 and fell as low as $200000.0 in Q2 2023.
  • Historically, Receivables - Other has averaged $442857.1 across 3 years, with a median of $400000.0 in 2022.
  • On a YoY basis, Receivables - Other climbed as much as 40.0% in 2023 and fell as far as 50.0% in 2023.
  • Year by year, Receivables - Other stood at $300000.0 in 2021, then jumped by 100.0% to $600000.0 in 2022, then plunged by 33.33% to $400000.0 in 2023.
  • Per Business Quant data, the three most recent Receivables - Other figures were $400000.0 in Q3 2023, $200000.0 in Q2 2023, and $700000.0 in Q1 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Mannkind 1.20 Bn 1.07 Bn 82.66 Mn

Historic Data

Download Data
DateValue
Sep 30, 2023 400,000.00
Sep 30, 2023 400,000.00
Jun 30, 2023 200,000.00
Jun 30, 2023 200,000.00
Mar 31, 2023 700,000.00
Mar 31, 2023 700,000.00
Sep 30, 2022 600,000.00
Sep 30, 2022 600,000.00
Jun 30, 2022 400,000.00
Jun 30, 2022 400,000.00
Mar 31, 2022 500,000.00
Mar 31, 2022 500,000.00
Dec 31, 2021 300,000.00
Dec 31, 2021 300,000.00
Sep 30, 2014 803,000.00
Sep 30, 2014 803,000.00
Sep 30, 2013 298,000.00
Sep 30, 2013 298,000.00
Jun 30, 2013 450,000.00
Jun 30, 2013 450,000.00